Rocket Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $10,312 |
Gross Profit | -2,339 | -2,254 | 5,156 |
EBITDA | -66,836 | -59,329 | -56,824 |
EBIT | -69,175 | -61,583 | -59,190 |
Net Income | -69,646 | -62,054 | -59,660 |
Net Change In Cash | 0 | 0 | 10,312 |
Free Cash Flow | -55,782 | -58,918 | -33,986 |
Cash | 38,607 | 35,276 | 55,904 |
Basic Shares | 93,746 | 93,549 | 84,009 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -7,098 | -6,266 | -5,373 | -1,145 |
EBITDA | -236,622 | -213,688 | -161,719 | -131,588 |
EBIT | -243,720 | -219,954 | -167,092 | -132,733 |
Net Income | -245,595 | -219,383 | -169,585 | -146,667 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -64,629 | 111,758 | ||
Free Cash Flow | -211,388 | -186,761 | -128,878 | -103,699 |
Cash | 55,904 | 140,517 | 232,694 | 297,098 |
Basic Shares | 84,009 | 68,148 | 63,235 | 55,380 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.71 |
2024-06-30 | -$0.74 |
2024-03-31 | -$0.66 |
2023-12-31 | -$0.64 |
